JUDY NEWMAN
608-252-6156
jdnewman@madison.com
Mithridion, a Madison biotech company that has been viewed as one of the area's promising startups, is getting a new lease on life.
The company at 505 Science Drive has merged with Cognitive Pharmaceuticals, of Toledo, Ohio. Terms were not announced this week, but the merged firm will be called Mithridion and will keep its headquarters in Madison.
Both companies were working on drug compounds to combat the effects of Alzheimer's disease on the brain. Cognitive's prospective drug appears to work, in preclinical studies. Mithridion's doesn't do what was hoped, the company realized late last year.
